Raphael Mohr
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 12
- Epidemiology 29
- Liver Disease Diagnosis and Treatment 19
- Neuroendocrine Tumor Research Advances 7
- Co-authors
- Frank Tacke (29 shared papers)Christoph Roderburg (28 shared papers)Jürgen K. Rockstroh (9 shared papers)Ulrich Spengler (7 shared papers)Christian P. Strassburg (9 shared papers)Maria A. González-Carmona (9 shared papers)Jonel Trebicka (8 shared papers)Leona Dold (9 shared papers)
In The Last Decade
Raphael Mohr
62 papers receiving 927 citations
Peers
Comparison fields: 5 of 77
- Hepatology 290
- Oncology 307
- Epidemiology 311
- Cancer Research 131
- Immunology 169
Countries citing papers authored by Raphael Mohr
This map shows the geographic impact of Raphael Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Mohr more than expected).
Fields of papers citing papers by Raphael Mohr
This network shows the impact of papers produced by Raphael Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Mohr. The network helps show where Raphael Mohr may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 120 | |
| 2 | 2019 | 51 | |
| 3 | 2014 | 46 | |
| 4 | 2021 | 43 | |
| 5 | 2023 | 35 | |
| 6 | 2021 | 34 | |
| 7 | High-dose MTX/5-FU and adriamycin for gastric cancer. | 1983 | 34 |
| 8 | 2015 | 33 | |
| 9 | 2020 | 33 | |
| 10 | 2023 | 29 | |
| 11 | 2018 | 28 | |
| 12 | 1974 | 24 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2020 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 19 | |
| 18 | 2018 | 17 | |
| 19 | 2019 | 16 | |
| 20 | 2021 | 16 |
About Raphael Mohr
Raphael Mohr is a scholar working on Oncology, Epidemiology, Hepatology, Pulmonary and Respiratory Medicine and Surgery, having authored 70 papers that have together received 942 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Liver Disease and Transplantation (12 papers), Gallbladder and Bile Duct Disorders (8 papers), Hepatitis C virus research (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Hepatology (290 citations), Oncology (307 citations), Epidemiology (311 citations), Cancer Research (131 citations) and Immunology (169 citations). Raphael Mohr has collaborated with scholars based in Germany, Spain and Denmark. Frequent co-authors include Frank Tacke, Christoph Roderburg, Jürgen K. Rockstroh, Ulrich Spengler, Christian P. Strassburg, Maria A. González-Carmona, Jonel Trebicka, Leona Dold, Annabelle Vogt and Münevver Demir. Their work appears in journals such as PLoS ONE, Cancers, Liver International, Journal of Clinical Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.